Key facts
- This page summarizes Michael Moore's Form 4 filing for VIEMED HEALTHCARE, INC. (VMD).
- 7 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 18 Jan 2023, 18:01.
Michael Moore - 17 Jan 2023 Form 4 Insider Report for VIEMED HEALTHCARE, INC. (VMD)
- Reporting relationship
- President
- Issuer ticker
- VMD
- Reported as of
- 17 Jan 2023
- Net transaction value
- -$73,737
- SEC form
- 4
- Accepted by SEC
- 18 Jan 2023, 18:01:11 UTC
- Prior SEC filing
- 10 May 2022
- Next SEC filing
- 11 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jesse Bergeron, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael Moore filed Form 4 for VIEMED HEALTHCARE, INC. (VMD) on 18 Jan 2023.
Change
- Previous filing in this sequence was filed on 10 May 2022.
- Current net transaction value: -$73,737.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VMD
transaction
Common Shares
Options Exercise
- Transaction value
- Shares
- +9,490
- Change %
- +0.53%
- Price
- Shares after
- 1,815,299
- Date
- 18 Jan 2023
- Ownership
- Direct
- Footnotes
- F1
VMD
transaction
Common Shares
Disposed to Issuer
- Transaction value
- $73,737
- Shares
- -9,490
- Change %
- -0.52%
- Price
- $7.77
- Shares after
- 1,805,809
- Date
- 18 Jan 2023
- Ownership
- Direct
VMD
transaction
Common Shares
Options Exercise
- Transaction value
- Shares
- +18,979
- Change %
- +1.1%
- Price
- Shares after
- 1,824,788
- Date
- 18 Jan 2023
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VMD
transaction
Derivative
Phantom Share Units
Options Exercise
- Transaction value
- $0
- Shares
- -9,490
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 18,978
- Date
- 18 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 9,490
- Exercise price
- Footnotes
- F1, F3
VMD
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -18,979
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 37,958
- Date
- 18 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 18,979
- Exercise price
- Footnotes
- F2, F4
VMD
transaction
Derivative
Phantom Share Units
Award
- Transaction value
- $0
- Shares
- +20,205
- Change %
- Price
- $0.000000
- Shares after
- 20,205
- Date
- 17 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 20,205
- Exercise price
- Footnotes
- F5, F6
VMD
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +80,818
- Change %
- Price
- $0.000000
- Shares after
- 80,818
- Date
- 17 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 80,818
- Exercise price
- Footnotes
- F2, F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
Footnote F2
Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
Footnote F3
Represents an award granted on January 18, 2022 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
Footnote F4
Restricted Stock Units (RSUs) granted to reporting person on January 18, 2022, which vest in three equal annual installments beginning on the first anniversary of the grant date.
Footnote F5
Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.
Footnote F6
Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
Footnote F7
Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date.
SEC remarks
Exhibit List: -Exhibit 24 Limited Power of Attorney